Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action modulators |
Mechanism HBG1 modulators(hemoglobin subunit gamma 1 modulators), HBG2 modulators(hemoglobin subunit gamma 2 modulators), c-Kit modulators(Stem cell growth factor receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | United States | 08 Dec 2024 | |
Anemia, Sickle Cell | Preclinical | United States | 08 Dec 2024 |